Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review

Johannes Burtscher; Hannes Gatterer; Beth A. Beidleman; Martin Burtscher

doi:10.1186/s40779-025-00634-y

Your Location：

Home >

Browse articles >

Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review

REVIEW | Updated：2026-03-26

- Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review
- Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review
- Military Medical Research 2026年13卷第1期页码：159-168
- Affiliations：
  
  1.Institute of Sport Sciences, University of Lausanne, 1015 Lausanne, Switzerland
  2.Institute of Mountain Emergency Medicine, Eurac Research, 39100 Bolzano, Italy
  3.Institute for Sports Medicine, Alpine Medicine and Health Tourism (ISAG), UMIT TIROL-Private University for Health Sciences and Health Technology, 6060 Hall in Tirol, Austria
  4.U.S. Army Research Institute of Environmental Medicine, Natick, MA 01760, USA
  5.Department of Sport Science, University of Innsbruck, 6020 Innsbruck, Austria
- Author bio：
  
  * Martin Burtscher martin.burtscher@uibk.ac.at
- Funds：
- DOI：10.1186/s40779-025-00634-y
  中图分类号：
- 收稿：2024-07-03，
  
  录用：2025-07-24，
  
  网络首发：2025-08-11，
  
  纸质出版：2026-01
- Accepted：
Scan QR Code
Johannes Burtscher, Hannes Gatterer, Beth A. Beidleman, 等. Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review[J]. Military Medical Research, 2026,13(1):159-168.

Johannes Burtscher, Hannes Gatterer, Beth A. Beidleman, et al. Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review[J]. Military Medical Research, 2026, 13(1): 159-168.
Johannes Burtscher, Hannes Gatterer, Beth A. Beidleman, 等. Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review[J]. Military Medical Research, 2026,13(1):159-168. DOI： 10.1186/s40779-025-00634-y.

Johannes Burtscher, Hannes Gatterer, Beth A. Beidleman, et al. Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review[J]. Military Medical Research, 2026, 13(1): 159-168. DOI： 10.1186/s40779-025-00634-y.

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Chinese expert consensus on prevention, diagnosis, and management of venous thromboembolism in adult burn patients (2024)

Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus

Risk factors for musculoskeletal injuries in the military: a qualitative systematic review of the literature from the past two decades and a new prioritizing injury model

Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary

Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review

Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review

DOI：10.1186/s40779-025-00634-y